Molecule to Market: Inside the outsourcing space

In this episode of Molecule to Market , you’ll go inside the outsourcing space of the global drug development sector with Mark Quick , Executive Vice President, Corporate Development at Recipharm . In the decade that Mark and Raman have known each other, Mark has risen from a BD role in a small Swedish CMO, to becoming one of the key leaders in a business that has transitioned into becoming one of...

In this episode of Molecule to Market , you’ll go inside the outsourcing space of the global drug development sector with Stefan Beyer , President and Managing Director at Vibalogics and Tom Hochuli , Chief Executive Officer at Vibalogics . Who is this dynamic duo you ask? Stefan has spent the bulk of his career in the vaccines and biologics space. He has been head of Vibalogics for almost 13 year...

In this special episode of  Molecule to Market , you’ll go inside the outsourcing space of the global drug development sector with host   Raman Sehgal , Founder & Global President at  ramarketing ,  Laura Child , CRO Sector Lead at  ramarketing , Dexter Tjoa , Chief Executive Officer at  Tjoapack,   Erik Haeffler , VP Manufacturing Services & Head of Sustainability at  Recipharm AB , John Ross , P...

In this special episode of  Molecule to Market , you’ll go inside the outsourcing space of the global drug development sector with host   Raman Sehgal , Founder & Global President at  ramarketing ,  Laura Child , CRO Sector Lead at  ramarketing , Roger Lias Chief Executive Officer at Stelis Biopharma Pvt. Ltd. and  Stelis Biopharma LLC , Mark Quick , Executive Vice President Corporate Development...

In this special episode of Molecule to Market , you’ll go inside the outsourcing space of the global drug development sector with host   Raman Sehgal , Founder & Global President at  ramarketing ,  Laura Child , CRO Sector Lead at  ramarketing , Torkel Gren , Senior Director, Technology Officer & Strategic Investments at  Recipharm,   Sascha Sonnenberg , Global Head of Business Development at  Sha...

In this special episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with host Raman Sehgal , Founder & Global President at ramarketing , Laura Child , CRO Sector Lead at ramarketing , Erik Haeffler , VP Manufacturing Services & Head of Sustainability at  Recipharm AB, Dan Stanton , Founder and Editor of  Bioprocess Insider and Stefano Console...

In this episode of Molecule to Market , you’ll go inside the outsourcing space of the global drug development sector with Shane Needham , Chief Founding Scientist, Director of the Board and Owner at Alturas Analytics, Inc. With a PHD in chemistry, Dr. Needham has spent almost 30 years in the sector. He started his career at Pfizer and went on to found his own company, Alturas Analytics, which focu...

In this episode of Molecule to Market , you’ll go inside the outsourcing space of the global drug development sector with Jason Lacombe , CEO at Veratrak . A graduate of Toronto and Oxford University, Jason was recently named as one of Forbes 30 Under 30 and has also advised the WHO and EU. Today, his business is one of the fastest growing tech companies in the life science space. Your host, Raman...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Mary Christian , Senior Vice President, Regulatory at Lyndra Therapeutics . To say Mary has an impressive track record is an understatement. Across the last three decades she has worked for some of the biggest pharmaceutical companies in the world including Janssen and Bristol M...

In this episode of  Molecule to Market , you’ll go inside the outsourcing space of the global drug development sector with  Sara Lesina , Global Marketing Director of Pharma & Nutrition, Capsules and Health Ingredients at  Lonza . A multilingual, international marketing leader, Sara oversees the global marketing and product line management team for the capsule business of Lonza, Capsugel®. Your ho...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Carl-Åke Carlsson CEO at Xellia Pharmaceuticals . Like celebrated “one-club” football stars like Leo Messi at Barcelona, Alessandro Del Piero at Juventus and Steven Gerrard at Liverpool… Carl-Åke has been with Xellia since 1988. A pharmaceutical leader known for his class and co...

In this episode of Molecule to Market , you’ll go inside the outsourcing space of the global drug development sector with Manuel Leal , Business Development Director at IDIFARMA . A student of law and business, Manuel has carved a very impressive career in the outsourcing space all despite having no formal pharma and science background! He has spent the last decade helping take a little known, loc...

In this episode of Molecule to Market , you’ll go inside the outsourcing space of the global drug development sector with Claire Thompson , CEO and Founder at Agility Life Sciences . Claire is an award winning pharmaceutical scientist with over 20 years of experience in developing pharma products, global companies, virtual biotechs and CROs. Today, Claire consults global health companies ranging f...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Kevin Orfan , President at Sharp . Kevin has been in the pharmaceutical and medical device industry for over 30 years and has incredible experience in the contract manufacturing space. He began his pharma career at Abbott Laboratories before moving to Hospira and then Pfizer Cen...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jeffrey Kiplinger , Co-Founder of Cohere Business Strategies and advisor and coach for entrepreneurs in the life science space. Jeffrey Co-Founded Research Operations Group in 2000, founded Averica Discovery Services in 2007, and has over 35 academic publications and holds a PhD...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gil Roth , Founder and President of the Pharma & Biopharma Outsourcing Association (PBOA) . Previous to launching PBOA in 2014, Gil helped launch Contract Pharma in 1999 and served as the founding editor for 15 years. Contract Pharma has since grown to become one of the most res...

In this episode of Molecule to Market , you’ll go inside the outsourcing space of the global drug development sector with Dexter Tjoa , CEO at Tjoapack . With a master's from Oxford University, Dexter joined Tjoapack about 5 years ago. His career has accelerated at an incredible speed since taking over the family business from his father, who founded Tjoapack over 30 years ago in the Netherlands....

In this episode of Molecule to Market , you’ll go inside the outsourcing space of the global drug development sector with Bobby Sheng , CEO and Chairman of Bora Pharmaceuticals .  A California native and an experienced leader in the pharmaceutical industry, Bobby is skilled in international business, management, mergers & acquisitions, finance, and marketing. He graduated from University of Califo...

In this episode of Molecule to Market , you’ll go inside the outsourcing space of the global drug development sector with John Ross , President at Mayne Pharma US . John Ross has spent 15 years in the pharma contract services space in senior roles following some time at Eli Lilly and PWC. He joined Mayne in 2013 as a VP and transitioned to President in 2017. Today, he oversees over 550+ people in...

In this episode of Molecule to Market , you’ll go inside the outsourcing space of the global drug development sector with Michael Quirmbach , Group Chief Executive Officer and President at Corden Pharma . Michael has been in the contract services space for 20 years. He joined Corden Pharma in 2014, holding positions as Vice President, Marketing and Sales and Chief Business Officer before becoming...

In this episode of Molecule to Market , you’ll go inside the outsourcing space of the global drug development sector with Eugene Ciolfi aka ‘Gene’, President and CEO at MedPharm . Gene has spent over 30 years in the CDMO space working for several renowned companies in senior roles along the way. It’s fair to say Gene has probably seen more than most in drug development! Your host, Raman Sehgal, di...

In this episode of Molecule to Market , you’ll go inside the outsourcing space of the global drug development sector with Detlef Behrens , founder at Bay Pharma . A PhD pharmacist by training, Detlef is a seasoned industry professional having spent 20 years in the pharmaceutical and biotechnology space. He’s worked for several global CDMOs and now runs a biotech company. He is one of a rare breed...

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with   Barbara Morgan , Global Business Director for Pharma and Nutra at Lubrizol . A PhD chemist by trade, Barbara has gone from working at the Broad Institute of MIT and Harvard in 2009, to heading the CDMO and Nutra division of Lubrizol, an incredible trajectory in 10 years. Along...

In this episode of Molecule to Market , you’ll go inside the outsourcing space of the global drug development sector with Dan Stanton , Editor and Founder of BioProcess Insider , an online publication focused on reporting the latest business news and opinion across the biomanufacturing space and part of the BioProcess International brand. Dan is also the Managing Editor at Xconomy and was formerly...

In this episode of Molecule to Market , you’ll go inside the outsourcing space of the global drug development sector with Stefano Console , a life science specialist with over 25 years of experience in the pharmaceutical and fine chemical sector. Stefano is the Senior Advisor at Oriento , a life sciences consultancy organization specializing in contract development and manufacturing organizations...